Showing results (331-340 of 343) with videos related to
Sort By:
Pageof 35
Physical Review Letters|September 5, 2001
Observation of zero current density in the core of jet discharges with lower hybrid heating and current driveN C Hawkes, B C Stratton, T Tala, et al.The Journal of Pediatrics|April 1, 1996
Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonatesG Bernstein, F L Mannino, G P Heldt, et al.The Journal of Pharmacology and Experimental Therapeutics|April 25, 2008
Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic ratsJames G Conway, Heather Pink, Mandy L Bergquist, et al.Journal of Medicinal Chemistry|November 16, 2001
Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)M H Rabinowitz, R C Andrews, J D Becherer, et al.Molecular Cell|December 14, 2001
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinasesY J Zhou, M Chen, N A Cusack, et al.Neuron|August 5, 1999
Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balanceS Hahm, T M Mizuno, T J Wu, et al.Journal of the American Academy of Dermatology|September 25, 1999
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair lossJ L Roberts, V Fiedler, J Imperato-McGinley, et al.Proceedings of the National Academy of Sciences of the United States of America|October 27, 2005
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580James G Conway, Brad McDonald, Janet Parham, et al.Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinasesJ G Conway, R C Andrews, B Beaudet, et al.Pageof 35